# Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs.

> **NCT05635929** · NA · RECRUITING · sponsor: **Mucosa Innovations, S.L.** · enrollment: 63 (estimated)

## Conditions studied

- Oral Mucositis
- Quality of Life
- Mucositis
- Pain
- Speech
- Saliva
- Radiation Toxicity
- Chemotherapeutic Toxicity
- Head and Neck Cancer

## Interventions

- **OTHER:** XCM-OM118 Composition comprising olive oil, betaine and xylitol

## Key facts

- **NCT ID:** NCT05635929
- **Lead sponsor:** Mucosa Innovations, S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-11
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05635929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05635929, "Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05635929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*